 |
 |

Central Monoamine Metabolism in ManEffect of Putative Dopamine Receptor Agonists and Antagonists
Thomas N. Chase, MD
Arch Neurol. 1973;29(5):349-351.
Abstract
The effect of haloperidol or piribedil (ET 495) on the central metabolism of dopamine (DA) and serotonin was examined in patients with various neurologic disorders. Monoamine turnover was estimated by the rate of accumulation in lumbar spinal fluid of the principle metabolites of these suspected neuromediators during the administration of probenecid. Haloperidol, which is believed to block DA receptors, appeared to accelerate DA turnover markedly, while piribedil, a suspected DA receptor agonist, substantially reduced the turnover of this monoamine. No consistent change in serotonin metabolism attended the administration of either drug. The results suggest that studies using pharmacologic agents that act on central monoaminergic receptors may provide an important means for evaluating mechanisms for controlling monoamine synthesis in patients with central nervous system disease.
Author Affiliations
Bethesda, Md
From the Neurology Unit, National Institute of Mental Health, Bethesda, Md.
Footnotes
Accepted for publication May 22, 1973.
Read in part before the Symposium International Trivastal, Monastir, Tunisia, Dec 1, 1972.
Reprint requests to Neurology Unit, NIH Clinical Center, 9000 Rockville Pike, Bethesda, MD 20014 (Dr. Chase).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Dopamine Metabolism in the Cerebrospinal Fluid of Drug-Free Schizophrenic Patients With and Without Cortical Atrophy
van Kammen et al.
Arch Gen Psychiatry 1986;43:978-983.
ABSTRACT
Brain Dopamine Turnover and the Relief of Parkinsonism
Rinne et al.
Arch Neurol 1977;34:626-629.
ABSTRACT
Response of Hemiballismus to Haloperidol
Gilbert
JAMA 1975;233:535-536.
ABSTRACT
Parkinson Disease Treated With a Suspected Dopamine Receptor Agonist
Chase et al.
Arch Neurol 1974;30:383-386.
ABSTRACT
|